- Home
- STNG vs AAPG Comparison
STNG vs AAPG Comparison
Compare STNG & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | STNG | AAPG |
|---|---|---|
| Founded | 2009 | 2009 |
| Country | Monaco | China |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.6B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | STNG | AAPG |
|---|---|---|
| Price | $73.46 | $23.88 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $79.00 | $48.50 |
| AVG Volume (30 Days) | ★ 1.1M | 1.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 2.39% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $368.64 |
| P/E Ratio | $10.06 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $31.62 | $17.56 |
| 52 Week High | $81.85 | $48.45 |
Technical Indicators
Market Signals| Indicator | STNG | AAPG |
|---|---|---|
| Relative Strength Index (RSI) | 54.22 | 47.56 |
| Support Level | $57.95 | $23.06 |
| Resistance Level | $81.85 | $26.01 |
| Average True Range (ATR) | 2.70 | 0.93 |
| MACD | -0.72 | 0.13 |
| Stochastic Oscillator | 23.51 | 62.79 |
Price Performance
Historical ComparisonAbout STNG Scorpio Tankers Inc.
Scorpio Tankers Inc is a provider of marine transportation of petroleum products. It owned, lease financed, or chartered in vessels spanning three different vessel segments Handymax, MR, and LR2. The company's fleet of tankers is the eco-friendly, and newest fleet on the water hauling clean petroleum products. It provides seaborne transportation of crude oil and refined petroleum products. The company generates the majority of its revenue from LR2.
About AAPG Ascentage Pharma Group International American Depository Shares
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.